What exosomes actually are
Start with the biology, because the marketing rarely does. Every cell in your body releases small membrane-enclosed packets into the space around it. These packets, far smaller than the cell itself, carry signalling molecules: proteins, lipids, fragments of genetic material. They travel to neighbouring cells and deliver their cargo, and those receiving cells respond. This is how cells coordinate with one another across tissue. The packets are called extracellular vesicles. The subgroup that has attracted most of the recent interest in regenerative medicine are the smallest of them, and those are what the field calls exosomes.
The reason regenerative medicine finds this interesting is the signalling itself. If damaged tissue releases certain signals, and those signals prompt surrounding cells to repair, then the question becomes whether you can deliver those signals in a more concentrated or directed way. That is the hypothesis the research is testing. It is a real hypothesis, grounded in real cell biology. The science that motivates the category is not invented. What is still being worked out is whether the preparations used in clinical practice reliably deliver what the hypothesis requires, in concentrations that matter, to the layers of tissue where the signalling would have effect.
How exosomes are used in aesthetic medicine
In aesthetic practice, exosome preparations are most often applied to the skin directly after a procedure that has deliberately opened it. Microneedling is the most common partner. A fractional laser is another. The reason for that timing is a physical one: on intact skin, most of a large molecule stays at the surface. It does not reach the dermal layers where the signalling biology would operate. A procedure that creates a controlled injury also creates a brief window during which the skin's barrier is compromised and the tissue beneath it is in active repair mode. That window is when an applied preparation has the best chance of reaching further than the surface.
This is why, across the field, exosomes are discussed almost entirely as a layered adjunct rather than a treatment in their own right. It also means that any result attributed to exosomes in a clinical photograph came from two treatments delivered together. The result you are being shown is the pair. Separating the contribution of the exosome layer from the contribution of the microneedling or laser beneath it is not something the current evidence can do cleanly, and most of the published work does not attempt to. That is not a reason to dismiss the category. It is a reason to read the evidence with the pairing in mind.
One further thing worth knowing: exosome preparations are not a standardised product. Source material, processing methods, and the concentration of what is actually delivered vary between preparations, and the standards governing that variation are still being settled across the field. Two clinics offering exosomes may be offering quite different things under the same name.
What the evidence does and does not yet show
The evidence for exosomes as an adjunct after microneedling or a laser is more developed than the evidence for exosomes used alone. Some controlled studies show faster recovery and improvements in skin texture and tone when exosomes are applied after a procedure, compared to the procedure without them. That is a meaningful signal. It is also a signal in a young body of literature, with small sample sizes, variable preparations, and follow-up periods that are still short by the standards of established dermatology research.
The evidence for exosomes used as a standalone treatment, applied to intact skin without a preceding procedure, is thinner. The delivery problem described above is part of why. A preparation that cannot reach the layer where the signalling would matter is, at best, an expensive moisturiser.
For a patient trying to make a sensible decision, developing evidence means this: no outcome should be promised, because the science has not yet earned that promise. Suitability is a consultation decision, made against a specific concern, not a menu item. And the relative strength of the evidence for the base treatment, the microneedling or the laser, is higher than for the exosome layer added on top of it. A clinic that leads its offering with the newest category is, at minimum, showing you its marketing before its clinical judgement. That is worth registering.
Why I do not offer them
I do not offer exosomes at The Retreat Clinic. The evidence has not finished grading it, and I am not willing to charge for that gap.
This is a position I hold for the same reason I hold it about any category where the marketing is running ahead of the science. The interesting thing about new science is watching it earn its claims. Some categories do earn them, over time, with accumulating evidence and better-standardised preparations. Some do not. Exosomes may be in the first group. The current evidence does not let me say that with the confidence I would need before putting them on a patient's plan and on an invoice.
If the evidence gets there, I will say so plainly. We will use them exactly as fast as the science allows, and no faster. The position on the treatment page says the same thing in more detail, and it will be updated if the evidence changes.
The questions worth asking any clinic that offers them
If you are considering exosomes at another clinic, the questions that matter are straightforward. What is this expected to add for my specific concern? What happens to the plan if we leave it out? What is actually in the preparation being used, and where does it come from? What does the current evidence say for the concern I am presenting with, not for the category in general?
A clinic that finds those questions inconvenient is answering a different question than you asked. A clinic that can answer them clearly, with an honest account of where the evidence sits, is worth your time regardless of what they conclude. The right answer to those questions might still be yes. It might be not yet. It should never be a claim the evidence cannot support.
The gap between promising and proven is where patients spend money on hope. Respecting that gap is the difference between medicine and marketing. That distinction is worth more than any individual treatment category, exosomes included. The concerns where these preparations are most discussed, texture, pores, and scarring, have other well-evidenced paths. It is worth knowing what those are before adding a layer whose contribution cannot yet be cleanly read. A piece on how the established collagen-stimulating approaches compare covers that ground.
A note on where the science goes next
The category will not stay still. Exosome research is active, preparation methods are improving, and the regulatory frameworks that govern these products are developing alongside the science in most markets. The Malaysian classification of exosome preparations in aesthetic medicine is not something I can state with confidence from published primary sources, and the treatment page reflects that deliberately: no regulatory claim is made where one cannot be verified.
What I can say is that the field is worth watching. The biology is real. The signalling hypothesis is not wishful thinking. Whether the clinical preparations used today reliably harness that biology, at the concentrations and delivery depths that matter, is the question the next several years of evidence will answer. I will be reading that evidence when it arrives, as I read it now: with interest, and without a prior commercial commitment to a particular answer.
